Human Cytomegalovirus Infection Downregulates Expression of the Cellular Aminopeptidases CD10 and CD13

• Published in: Virology (New York, N.Y.) N.Y.), 1998-10, Vol.250 (2), p.350-358
• Main Authors: Phillips, A.J., Tomasec, P., Wang, E.C.Y., Wilkinson, G.W.G., Borysiewicz, L.K.
• Format: Article
• Language: English
• Subjects: CD13 Antigens - genetics; CD13 Antigens - metabolism; Cell Line, Transformed; Cell Membrane - metabolism; Cells, Cultured; Cytomegalovirus - physiology; Cytomegalovirus Infections - metabolism; Down-Regulation; Human cytomegalovirus; Humans; Neprilysin - genetics; Neprilysin - metabolism; RNA, Messenger
• ISSN: 0042-6822; 1096-0341
• DOI: 10.1006/viro.1998.9385

During the course of a productive infection, human cytomegalovirus (HCMV) has a sophisticated relationship with its host cell. An increasing number of virus-encoded genes are being identified which act specifically to usurp or modulate functions in the host cell associated with transcriptional control, cell signalling, and protein synthesis. While HCMV infection is associated with a general upregulation of cellular gene expression, the expression a small subset of cellular proteins, including the MHC-1 heavy chain and fibronectin, is downregulated. This study now identifies two additional cellular proteins, aminopeptidase N (CD13) and neutral endopeptidase (CD10), that are downregulated during HCMV infection. While aminopeptidase N and neutral endopeptidase exhibit no significant sequence homology, both are expressed on the cell surface and have very similar enzymatic properties. HCMV infection was associated with reduced surface expression and enzyme activity of CD13 and CD10, an apparent decrease in the rate of synthesis of both proteins in metabolic-labelling experiments, and inhibited glycosylation of the nascent CD13 and CD10 polypeptide chains that were synthesized. Levels of CD10 poly A+RNA were suppressed efficiently at all stages of virus infection; however, the reduction in CD13 poly A+RNA levels was much less pronounced. This differential effect suggests that HCMV may be downregulating expression of CD10 and CD13 by independent mechanisms. Indeed, treatment of cells with an inhibitor of viral DNA synthesis blocks downregulation of CD13, whilst downregulation of CD10 is unaffected. While it is not yet clear what advantage is bestowed on the virus by downregulating expression of CD13 and CD10, aminopeptidases are known to have a role in peptide processing in both the MHC class I the MHC class II antigen presentation pathways.